Activation of interferon regulatory factor 5 by site specific phosphorylation

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Foreman, Hui Chen Chang ^a   van Scoy, Sarah ^a   Cheng, Tsu Fan ^a   Reich, Nancy C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; BINDING PROTEIN; CARBOXYLSERINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERFERON REGULATORY FACTOR 5; RECEPTOR INTERACTING PROTEIN 2; SERINE DERIVATIVE; TANK BINDING KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; INTERFERON REGULATORY FACTOR; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2;

AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION INITIATION; UBIQUITINATION; ANIMAL; CELL LINE; CELL NUCLEUS; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; PROTEIN TRANSPORT; SITE DIRECTED MUTAGENESIS;

ANIMALS; APOPTOSIS; CELL LINE; CELL NUCLEUS; HUMANS; INTERFERON REGULATORY FACTORS; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSCRIPTIONAL ACTIVATION; UBIQUITINATION;

EID: 84857846174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033098     Document Type: Article

References (59)

1. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76: 528-537.
2. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38: 550-555.
3. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104: 6758-6763.
4. Ferreiro-Neira I, Calaza M, Alonso-Perez E, Marchini M, Scorza R, et al. (2007) Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun 8: 429-438.
5. Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, et al. (2008) Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 9: 187-194.
6. Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, et al. (2011) Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum 63: 738-748.
7. Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, et al. (2010) IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. Journal of Immunology 184: 796-806.
8. Lien C, Fang CM, Huso D, Livak F, Lu R, et al. (2010) Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A 107: 4664-4668.
9. Savitsky DA, Yanai H, Tamura T, Taniguchi T, Honda K, (2010) Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci U S A 107: 10154-10159.
10. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243-249.
11. Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, et al. (2005) Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 280: 21078-21090.
12. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, et al. (2002) Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 21: 2914-2918.
13. Kokkinakis DM, Liu X, Chada S, Ahmed MM, Shareef MM, et al. (2004) Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. Cancer Res 64: 7513-7525.
14. Cheng TF, Brzostek S, Ando O, Van Scoy S, Kumar KP, et al. (2006) Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J Immunol 176: 7462-7470.
15. Lin RT, Yang L, Arguello M, Penafuerte C, Hiscott J, (2005) A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. Journal of Biological Chemistry 280: 3088-3095.
16. Balkhi MY, Fitzgerald KA, Pitha PM, (2008) Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol Cell Biol 28: 7296-7308.
17. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, et al. (2005) The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. Journal of Biological Chemistry 280: 17005-17012.
18. Barnes BJ, Moore PA, Pitha PM, (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. Journal of Biological Chemistry 276: 23382-23390.
19. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, et al. (2007) Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J Biol Chem 282: 4102-4112.
20. Yang WL, Wang J, Chan CH, Lee SW, Campos AD, et al. (2009) The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325: 1134-1138.
21. Yang Y, Yin C, Pandey A, Abbott D, Sassetti C, et al. (2007) NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J Biol Chem 282: 36223-36229.
22. Wu H, Arron JR, (2003) TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25: 1096-1105.
23. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, et al. (2008) A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 27: 373-383.
24. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, et al. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178: 2380-2386.
25. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, et al. (2002) RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199.
26. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, et al. (2002) Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416: 190-194.
27. Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, et al. (2008) The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28: 381-390.
28. Barnes BJ, Kellum MJ, Field AE, Pitha PM, (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Molecular and Cellular Biology 22: 5721-5740.
29. Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM, (2003) Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Research 63: 6424-6431.
30. Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, et al. (2009) NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 5: e1000500.
31. Kersse K, Bertrand MJ, Lamkanfi M, Vandenabeele P, (2011) NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev 22: 257-276.
32. Sorbara MT, Philpott DJ, (2011) Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis. Immunol Rev 243: 40-60.
33. Chen G, Shaw MH, Kim YG, Nunez G, (2009) NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 4: 365-398.
34. Kudo N, Wolff B, Sekimoto T, Schreiner EP, Yoneda Y, et al. (1998) Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 242: 540-547.
35. Pickart CM, Fushman D, (2004) Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 8: 610-616.
36. Ning S, Pagano JS, (2010) The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J Virol 84: 6130-6138.
37. Komander D, Barford D, (2008) Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J 409: 77-85.
38. Harhaj EW, Dixit VM, (2011) Deubiquitinases in the regulation of NF-kappaB signaling. Cell Res 21: 22-39.
39. Tao M, Scacheri PC, Marinis JM, Harhaj EW, Matesic LE, et al. (2009) ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr Biol 19: 1255-1263.
40. Hu G, Mancl ME, Barnes BJ, (2005) Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res 65: 7403-7412.
41. Hu G, Barnes BJ, (2009) IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. J Biol Chem 284: 2767-2777.
42. Stawowczyk M, Van Scoy S, Kumar KP, Reich NC, (2011) The interferon stimulated gene 54 promotes apoptosis. J Biol Chem 286: 7257-7266.
43. Lee MS, Kim YJ, (2007) Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76: 447-480.
44. Tamura T, Yanai H, Savitsky D, Taniguchi T, (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26: 535-584.
45. Richez C, Barnetche T, Miceli-Richard C, Blanco P, Moreau JF, et al. (2010) Role for interferon regulatory factors in autoimmunity. Joint Bone Spine 77: 525-531.
46. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin RT, et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
47. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. (2003) IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunology 4: 491-496.
48. Lin RT, Mamane Y, Hiscott J, (1999) Structural and functional analysis of interferon regulatory factor 3: Localization of the transactivation and autoinhibitory domains. Molecular and Cellular Biology 19: 2465-2474.
49. Mori M, Yoneyama M, Ito T, Takahashi K, Inagaki F, et al. (2004) Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. Journal of Biological Chemistry 279: 9698-9702.
50. Panne D, McWhirter SM, Maniatis T, Harrison SC, (2007) Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J Biol Chem 282: 22816-22822.
51. Abbott DW, Yang Y, Hutti JE, Madhavarapu S, Kelliher MA, et al. (2007) Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol Cell Biol 27: 6012-6025.
52. Magalhaes JG, Lee J, Geddes K, Rubino S, Philpott DJ, et al. (2011) Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands. Eur J Immunol 41: 1445-1455.
53. Chen W, Lam SS, Srinath H, Jiang Z, Correia JJ, et al. (2008) Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat Struct Mol Biol 15: 1213-1220.
54. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699.
55. Lin R, Yang L, Nakhaei P, Sun Q, Sharif-Askari E, et al. (2006) Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 281: 2095-2103.
56. Wang YY, Li LY, Han KJ, Zhai ZH, Shu HB, (2004) A20 is a potent inhibitor of TLR3-and Sendai virus-induced activation of NF-kappa B and ISRE and IFN-beta promoter. Febs Letters 576: 86-90.
57. Lin RT, Mamane Y, Hiscott J, (2000) Multiple regulatory domains control IRF-7 activity in response to virus infection. Journal of Biological Chemistry 275: 34320-34327.
58. Zhao J, Kong HJ, Li H, Huang B, Yang M, et al. (2006) IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J Biol Chem 281: 10073-10080.
59. Jura N, Scotto-Lavino E, Sobczyk A, Bar-Sagi D, (2006) Differential modification of Ras proteins by ubiquitination. Mol Cell 21: 679-687.